5 unknown, 1 recruiting. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Unknown 5, Recruiting 1 |
Follow Chidamide: new trials by email Literature Review of Chidamide trials Research Report on Chidamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia Chidamide, Venetoclax, azacitidine - AML, Acute Myeloid Leukemia | Not applicable | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 184 | 2024-08-05 | 2025-08-03 |
| A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy Chidamide - HR Positive HER2 Negative Advanced Breast Cancer | Not applicable | Unknown | Tianjin Medical University Cancer Institute and Hospital | 60 | 2023-05-16 | 2023-06-06 |
| Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Chidamide, Fulvestrant - Advanced Breast Cancer | Not applicable | Unknown | Liaoning Cancer Hospital & Institute | 82 | 2021-08-18 | 2021-09-17 |
| Rituximab Combined With Chidamide and Lenalidomide for r/r AITL Rituximab - Angioimmunoblastic T-cell Lymphoma, Chemotherapy Effect | Not applicable | Unknown | Zhejiang Cancer Hospital | 26 | 2020-03-13 | 2021-03-24 |
| Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) Chidamide - Peripheral T Cell Lymphoma | Not applicable | Unknown | The First Affiliated Hospital of Soochow University | 39 | 2017-06-15 | 2017-08-31 |
| Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma Chidamide - Lymphoma | Not applicable | Unknown | Chinese Academy of Medical Sciences | 76 | 2014-08-01 | 2020-08-13 |
Immunoblastic Lymphadenopathy (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphoma, T-Cell, Peripheral (1)
Chinese Academy of Medical Sciences (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Liaoning Cancer Hospital & Institute (1) · The First Affiliated Hospital of Soochow University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Zhejiang Cancer Hospital (1)
China (6)
Jianxiang Wang, MD (1) · Li Zhang (1) · Mei Dong (1) · Ming Chen, PhD (1) · Zhengming Jin, MD,PhD (1)